New drug could cut cost of arthritis treatment

被引：0
|
作者：
不详
机构：
来源：
TCE | 2003年 / 748期
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [41] Drug industry cost pressure could benefit chemical firms
    Mullin, R
    CHEMICAL WEEK, 2002, 164 (25) : 26 - 28
  • [42] TENIDAP - A NEW DRUG FOR ARTHRITIS
    OTTERNESS, IG
    CARTY, TJ
    LOOSE, LD
    THERAPEUTIC APPROACHES TO INFLAMMATORY DISEASES, 1989, : 229 - 241
  • [43] Could oral Janus kinase inhibitor be a new drug treatment for active ulcerative colitis?
    Natalie J. Wood
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 (10) : 557 - 557
  • [44] Cost implications of introducing rituximab as a new treatment modality for rheumatoid arthritis in Germany
    Schach, S.
    Rubbert, A.
    Diamantopoulos, A.
    Aristides, M.
    Kielhorn, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 600 - 601
  • [45] Cost-effectiveness of rituximab as a new treatment modality for rheumatoid arthritis in Germany
    Rubbert, A
    Kielhorn, A
    Schach, S
    Brown, B
    Aristides, M
    VALUE IN HEALTH, 2006, 9 (03) : A25 - A25
  • [46] MODIFIED CANCER DRUG COULD EASE TREATMENT
    不详
    NEW SCIENTIST, 1988, 118 (1617) : 41 - 41
  • [47] Rheumatoid Arthritis: State of the Treatment Cost
    Mavlyanov, I. R.
    Bekenova, G. T.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2014, 4 (04) : S38 - S41
  • [48] Technology could cut CO2 cost sharply for enhanced oil recovery
    Henni, Abdelahani
    Henni, A., 1600, Society of Petroleum Engineers (SPE) (66): : 30 - 32
  • [49] Drug cost per responder for the treatment of moderate-to-severe psoriasis and active psoriatic arthritis
    Armstrong, April
    Merola, Joseph
    Yang, Min
    Li, Junlong
    Zhao, Jing
    Sundaram, Murali
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB105 - AB105
  • [50] Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis
    Pflugbeil, Stephan
    Boeckl, Karin
    Pongratz, Reinhold
    Leitner, Marianne
    Graninger, Winfried
    Ortner, Astrid
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (04) : 511 - 521
12345